Prados, Ferran
Cardoso, M. Jorge
Yiannakas, Marios C.
Hoy, Luke R.
Tebaldi, Elisa
Kearney, Hugh
Liechti, Martina D.
Miller, David H.
Ciccarelli, Olga
Wheeler-Kingshott, Claudia A. M. Gandini
Ourselin, Sebastien
Article History
Received: 27 June 2016
Accepted: 6 October 2016
First Online: 27 October 2016
Competing interests
: FP, MJC, MY, LH, ET, HK, ML, CWK and SO declare no competing financial interests. DM has received honoraria through payments to his employer, UCL Institute of Neurology, for Advisory Committee and/or Consultancy advice in multiple sclerosis studies from Biogen Idec, GlaxoSmithKline, Novartis, Merck, Chugai, Mitsubishi Pharma Europe and Bayer Schering Pharma. He has also received compensation through payments to my employer for performing central MRI analysis of multiple sclerosis trials from GlaxoSmithKline, Biogen Idec, Novartis and Merck. OC is a consultant for Novartis, Biogen-Idec, Genzyme and General Electric, and all the payments are made to the UCL Institute of Neurology. She is an associate editor of Neurology.